These effects were mediated via CB1R located either in podocytes and/or RPTCs, since their specific nullification from these cells completely prevented the development of hyperglycemia- or lipotoxicity-induced renal dysfunction. The gene discussed is CNR1; the disease is Hyperglycemia.